I just picked up this tidbit from TK out of the transcript of the conference call on Friday...Hmmm.
Anthony Keating, ResApp Health Limited - CEO, MD & Director [17] --------------------------------------------------------------------------------" Look, there are some signs that cough-based analysis could pick up COVID-19 with a number of groups globally looking at that. And I think I've said this before in quarterly. We are looking at that opportunity. But right now, we don't have anything material to report. We haven't run a clinical study or started a clinical study in that area just yet."-------
AstraZeneca are perfect for Covid cough (sounds) gathering are they not? The cancer cough counting doesn't do it for me...TK says here that they are actually looking at that opportunity but nothing to report at the moment...tick tock.
- Forums
- ASX - By Stock
- RAP
- Ann: Quarterly Activities Report and Appendix 4C
Ann: Quarterly Activities Report and Appendix 4C, page-258
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LGP
Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast